Skip to content

A Clinical Study on the Efficacy and Safety of Thoracoscopy Combined with Laparoscopy, Robotics, and Transcervical Mediastinoscopy Combined with Laparoscopy in the Treatment of Esophageal Cancer

A Clinical Study on the Efficacy and Safety of Thoracoscopy Combined with Laparoscopy, Robotics, and Transcervical Mediastinoscopy Combined with Laparoscopy in the Treatment of Esophageal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125911
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Thoracoscopy group:None
Transcervical mediastinoscopy group:None

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed esophageal cancer; 2. Clinical stage I–III (according to the AJCC staging system for esophageal cancer); 3. Scheduled to undergo surgical treatment with thoracoscopy combined with laparoscopy, robotic surgery, or transcervical mediastinoscopy combined with laparoscopy; 4. Aged 18–75 years, regardless of gender; 5. Eastern Cooperative Oncology Group (ECOG) performance status score of 0–2; 6. Adequate function of major organs to tolerate surgery and follow-up; 7. Informed consent obtained from the patient and their family, voluntary participation in this study, and signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Esophageal cancer with non-squamous, non-adenocarcinoma histology; 2. Clinical stage IV (with distant metastasis); 3. Prior history of major thoracic or abdominal surgery; 4. Severe concomitant diseases of vital organs (heart, lung, liver, kidney, etc.) that preclude tolerance to surgery; 5. Concomitant other malignant tumors; 6. Presence of psychiatric disorders that preclude compliance with follow-up; 7. Pregnant or lactating women; 8. Refusal to sign the informed consent form or inability to complete the required follow-up.

Design outcomes

Primary

MeasureTime frame
baseline characteristics;surgical outcomes ;postoperative recovery indicators;safety parameters;Long-term outcomes;

Countries

China

Contacts

Public ContactZhenyang Zhang

Fujian Medical University Union Hospital

huangjiangshan2013@163.com+86 183 5017 8907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026